Alamar Biosciences, Inc. (ALMR) Stock

Healthcare · Medical Devices · Member of Other US Stocks

Alamar Biosciences, Inc. (ALMR) closed at USD 25.37 on 2026-10-14, a change of +15.3 % over the past year, with a market capitalization of USD 1.9B.

Alamar Biosciences, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Alamar Biosciences, Inc. key figures

Previous close

USD 25.37 (2026-10-14)

1-year change

+15.3 %

Market cap

USD 1.9B

Enterprise value

USD 1.7B

P/E ratio (trailing)

-19.59

P/E ratio (forward)

-60.69

EPS (trailing)

-1.40

EPS (forward)

-0.45

PEG ratio

n/a

Price to book

6.08

Revenue growth

82.1 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

5.95

Employees

286

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Alamar Biosciences, Inc.

Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, translational research and ultimately, and diagnostics. The company's offering is utilized in research areas including immunology, neurology, and oncology. It serves global research and academic institutions, biopharmaceutical companies, contract research organizations, and service labs. The company operates in the United States, rest of Europe, Middle East and Africa, Germany, Asia Pacific, and internationally. It has a strategic partnership with Alzheimer's Disease Data Initiative, and Gates Ventures to advance translational research in alzheimer's disease. The company was incorporated in 2018 and is based in Fremont, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Alamar Biosciences, Inc. and compare it with other stocks.